Have your own idea? Try our Stock Screener
UPDATED Nov 27, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
IVVD | US$0.67 | 14.3% | -55.6% | US$70.6m | US$6.51 | PS7x | E72.2% | n/a | ||
MYGN | US$16.28 | 0.7% | -15.4% | US$1.5b | US$23.79 | PS1.8x | E56.9% | n/a | ||
SLN | US$7.67 | 2.8% | -40.4% | US$352.2m | US$53.70 | PS17.6x | E-3.1% | n/a | ||
CRVO | US$9.16 | 14.7% | -7.8% | US$65.9m | US$50.29 | PS7.5x | E-42.9% | n/a | ||
ARTV | US$12.60 | 3.2% | n/a | US$296.6m | US$21.25 | PS117.7x | E-20.6% | n/a | ||
GHRS | US$9.28 | 2.0% | 49.9% | US$473.5m | US$31.25 | PB2.5x | E-6.9% | n/a | ||
XCUR | US$31.99 | 15.5% | 1,261.3% | US$60.2m | n/a | PS139x | n/a | n/a | ||
JSPR | US$23.24 | 2.7% | 293.9% | US$339.5m | US$69.50 | PB4.2x | E-16.4% | n/a | ||
HRTX | US$1.16 | 5.5% | -10.8% | US$167.3m | US$6.00 | PS1.3x | E71.2% | n/a | ||
UNCY | US$0.68 | 14.9% | 32.7% | US$61.3m | US$5.50 | PB2.5x | E58.8% | n/a | ||
NOTV | US$3.54 | 11.0% | 38.8% | US$83.0m | US$5.33 | PB0.5x | E31.7% | n/a | ||
TLRY | US$1.37 | 0.7% | -24.3% | US$1.2b | US$2.20 | PS1.5x | E72.0% | n/a | ||
TBPH | US$9.42 | 1.9% | -10.0% | US$454.4m | US$13.20 | PS7.3x | E73.1% | n/a | ||
IMMX | US$1.97 | 19.4% | -61.2% | US$45.4m | US$7.00 | PB3.1x | E3.4% | n/a | ||
CKPT | US$4.28 | 4.4% | 67.5% | US$200.2m | US$17.00 | PS4446.9x | E102.7% | n/a | ||
ALDX | US$4.94 | 2.9% | 78.3% | US$285.8m | US$10.00 | PB3.5x | E71.6% | n/a | ||
CERO | US$0.20 | 37.6% | -98.1% | US$22.1m | n/a | PE-5.5x | n/a | n/a | ||
MNKD | US$6.61 | 0.5% | 86.7% | US$1.8b | US$9.25 | PE84.5x | E39.7% | n/a | ||
ZYME | US$14.42 | 0.8% | 63.5% | US$984.9m | US$17.86 | PS16x | E6.7% | n/a | ||
CUE | US$1.22 | 11.9% | -45.3% | US$69.1m | US$3.60 | PS8.1x | E-2.1% | n/a | ||
RCKT | US$14.20 | 0.6% | -37.9% | US$1.3b | US$46.79 | PB3.9x | E55.2% | n/a | ||
HROW | US$42.47 | 0.5% | 372.4% | US$1.5b | US$60.85 | PS8.9x | E83.7% | n/a | ||
THRD | US$13.11 | 1.4% | 61.3% | US$582.6m | US$19.00 | PB2x | E-28.4% | n/a | ||
CGEN | US$1.61 | 5.9% | 140.7% | US$136.1m | US$4.00 | PE90.2x | E-59.8% | n/a |